Encompass Health Corp. 8-K Summary
Business Context and Reporting Period
Encompass Health Corporation (EHC) filed this Form 8-K on February 5, 2026, to report financial results for the three months and full year ended December 31, 2025. The filing incorporates a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) detailing the Company's performance. An earnings call was scheduled for February 6, 2026.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it defines the non-GAAP measures used to assess performance:
- Adjusted Earnings Per Share: Excludes government settlements, professional fees, mark-to-market adjustments, hedging gains/losses, debt extinguishment losses, tax provision adjustments, and restructuring items.
- Leverage Ratio: Defined as consolidated total debt to Adjusted EBITDA for the trailing four quarters. The credit agreement permits deducting cash on hand from total debt.
- Adjusted EBITDA: Used as a liquidity measure and a key component of credit covenants. It adjusts net income by adding back interest, taxes, depreciation, amortization, and specific non-recurring items (capped at $10 million for cash expenditures).
- Adjusted Free Cash Flow: Calculated as net cash from operating activities minus maintenance capital expenditures, distributions to noncontrolling interests, and non-indicative items. Dividends are excluded.
Material Changes and Comparisons
The Company utilizes "same-store" comparisons to explain performance changes, calculated based on hospitals open throughout both the current and prior periods. These comparisons include results from market consolidation transactions and capacity expansions in existing markets. The filing does not explicitly state the magnitude of changes versus the prior period, referring investors to the attached press release for specific data.
Guidance, Risks, and Contingencies
Covenant Compliance: The Company's credit agreement includes material covenants regarding the interest coverage ratio and leverage ratio. Noncompliance could trigger immediate repayment of all borrowed amounts, prohibit additional indebtedness, and restrict dividends or asset acquisitions. Adjusted EBITDA is critical for assessing compliance.
Forward-Looking Statements: The filing contains estimates regarding future events, business strategy, labor cost trends, dividend strategies, and legislative impacts. These are subject to risks and uncertainties that may cause actual results to differ materially.
Non-GAAP Limitations: Management notes that adjusted measures are not substitutes for GAAP measures and may not be comparable to similarly titled measures of other companies due to varying calculations.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial figures for Q4 and Full Year 2025.
- Verify the Company's current leverage ratio and interest coverage ratio against credit agreement covenants.
- Examine the reconciliation of Adjusted EBITDA to net income to understand the magnitude of excluded items.
- Check the 2025 Form 10-K (when filed) for detailed accounting policies and consolidated cash flow statements.
- Assess the impact of "same-store" comparisons on reported growth metrics versus organic growth.